FDx Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

FDx Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,800	Closed	-$208K	–	1048
2015 Q1	$208K	Buy	+3,800	New	+$181K	﹤0.01%	1432

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FDx Advisors's AMAG Position: Q2 2015 in Review

FDx Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q2 2015, closing a stake of 3,800 shares — an estimated $208K sold.

FDx Advisors first reported a position in AMAG in Q1 2015 and held it in 1 quarter. The position peaked at $208K in Q1 2015. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

FDx Advisors reported no remaining AMAG Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
FDx Advisors sold 3,800 AMAG Pharmaceuticals shares in Q2 2015, an estimated $208K.
FDx Advisors first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 1 quarter.
FDx Advisors's AMAG Pharmaceuticals position peaked at $208K in Q1 2015.
208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on FDx Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.